Report

1 INTRODUCTION 38
1.1 STUDY OBJECTIVES 38
1.2 MARKET DEFINITION 38
1.3 MARKET SCOPE 39
1.3.1 MARKETS & REGIONS COVERED 39
1.3.2 INCLUSIONS & EXCLUSIONS 40
1.3.3 YEARS CONSIDERED 40
1.3.4 CURRENCY CONSIDERED 41
1.4 STAKEHOLDERS 41
1.5 SUMMARY OF CHANGES 41
2 RESEARCH METHODOLOGY 43
2.1 RESEARCH DATA 43
2.1.1 SECONDARY DATA 44
2.1.2 PRIMARY RESEARCH 45
2.2 MARKET SIZE ESTIMATION 46
2.2.1 GLOBAL MARKET ESTIMATION 46
2.2.1.1 Insights from primary experts 48
2.2.2 SEGMENTAL MARKET ESTIMATION (TOP-DOWN APPROACH) 49
2.3 MARKET GROWTH RATE PROJECTIONS 50
2.4 DATA TRIANGULATION 52
2.5 RESEARCH ASSUMPTIONS 53
2.6 RESEARCH LIMITATIONS 54
2.7 RISK ANALYSIS 54
3 EXECUTIVE SUMMARY 55
4 PREMIUM INSIGHTS 60
4.1 CLINICAL TRIAL SUPPLIES MARKET OVERVIEW 60
4.2 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE AND COUNTRY (2024) 61
4.3 CLINICAL TRIAL SUPPLIES MARKET SHARE, BY TYPE, 2025 VS. 2030 61
4.4 CLINICAL TRIAL SUPPLIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 64
5.2.1 DRIVERS 65
5.2.1.1 Growth in clinical trials & drug development 65
5.2.1.2 Expansion of global and multicenter trials accelerating demand for clinical trial supplies 66
5.2.1.3 Rising demand for personalized medicine and biologics 66
5.2.2 RESTRAINTS 67
5.2.2.1 High costs associated with clinical trial supplies 67
5.2.3 OPPORTUNITIES 67
5.2.3.1 Rise in decentralized and virtual trials 67
5.2.3.2 Integration of digital technologies in supply chain management 68
5.2.4 CHALLENGES 68
5.2.4.1 Supply chain disruptions and drug shortages 68
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 69
5.4 VALUE CHAIN ANALYSIS 69
5.5 ECOSYSTEM ANALYSIS 72
5.5.1 CLINICAL TRIAL SUPPLIES MARKET: RAW MATERIAL PROVIDERS 73
5.5.2 CLINICAL TRIAL SUPPLIES MARKET: SERVICE PROVIDERS 73
5.5.3 CLINICAL TRIAL SUPPLIES MARKET: END USERS 74
5.5.4 CLINICAL TRIAL SUPPLIES MARKET: REGULATORY BODIES 74
5.6 PRICING ANALYSIS 75
5.6.1 AVERAGE SELLING PRICE, BY KEY PLAYER (QUALITATIVE) 75
5.6.2 INDICATIVE PRICE, BY SERVICE (QUALITATIVE) 76
5.7 INVESTMENT AND FUNDING SCENARIO 77
5.8 TECHNOLOGY ANALYSIS 77
5.8.1 KEY TECHNOLOGIES 77
5.8.1.1 Serialization & track-and-trace technologies 77
5.8.1.2 Interactive response technology (IRT/IVR/IWR) 78
5.8.1.3 Cold chain & temperature monitoring solutions 78
5.8.2 COMPLEMENTARY TECHNOLOGIES 78
5.8.2.1 Artificial intelligence (AI) & machine learning (ML) 78
5.8.2.2 Blockchain for supply chain transparency 78
5.8.3 ADJACENT TECHNOLOGIES 78
5.8.3.1 Cryopreservation & advanced storage technologies 78
5.8.3.2 Advanced robotics in warehousing & distribution 79
5.9 KEY CONFERENCES AND EVENTS, 2025-2026 79
5.10 REGULATORY LANDSCAPE 80
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.10.2 REGULATORY FRAMEWORK 83
5.10.2.1 North America 83
5.10.2.1.1 US 83
5.10.2.1.2 Canada 84
5.10.2.2 Europe 84
5.10.2.2.1 Germany 84
5.10.2.2.2 France 84
5.10.2.2.3 Italy 84
5.10.2.3 Asia Pacific 84
5.10.2.3.1 Japan 84
5.10.2.3.2 China 84
5.10.2.3.3 India 84
5.10.2.4 Latin America 85
5.10.2.4.1 Brazil 85
5.10.2.5 Middle East & Africa 85
5.10.2.5.1 GCC Countries 85
5.10.2.5.2 South Africa 85
5.11 PORTER'S FIVE FORCES ANALYSIS 85
5.11.1 THREAT OF NEW ENTRANTS 86
5.11.2 BARGAINING POWER OF SUPPLIERS 86
5.11.3 BARGAINING POWER OF BUYERS 87
5.11.4 THREAT OF SUBSTITUTES 87
5.11.5 INTENSITY OF COMPETITIVE RIVALRY 87
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 87
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
5.12.2 BUYING CRITERIA 89
5.13 IMPACT OF AI/GENERATIVE AI ON CLINICAL TRIAL SUPPLIES MARKET 90
5.13.1 INTRODUCTION 90
5.13.2 FUTURE OF GENERATIVE AI IN CLINICAL TRIAL SUPPLIES ECOSYSTEM 92
6 CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE 93
6.1 INTRODUCTION 94
6.2 LOGISTICS & DISTRIBUTION SERVICES 94
6.2.1 RISING DEMAND DUE TO INCREASING EMPHASIS ON CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH 94
6.3 COMPARATOR SOURCING SERVICES 98
6.3.1 RISING DEMAND FOR COMPARATOR SOURCING TO DRIVE MARKET 98
6.4 PACKAGING, LABELING, AND BLINDING SERVICES 101
6.4.1 PRIMARY PACKAGING SERVICES 105
6.4.1.1 Increasing demand for innovative drug formulations to support market growth 105
6.4.2 SECONDARY PACKAGING SERVICES 108
6.4.2.1 Increasing complexity of global clinical trials to propel market 108
6.4.3 LABELING & BLINDING SERVICES 111
6.4.3.1 Rising number of randomized and double-blind studies to propel market 111
?
6.5 MANUFACTURING SERVICES 114
6.5.1 RISING DEMAND FOR ULTRA-LOW-TEMPERATURE STORAGE TO DRIVE GROWTH 114
6.6 STORAGE & RETENTION SERVICES 117
6.6.1 RISING DEMAND FOR ULTRA-LOW-TEMPERATURE STORAGE TO DRIVE GROWTH 117
6.7 OTHER SERVICES 121
7 CLINICAL TRIAL SUPPLIES MARKET, BY PHASE 125
7.1 INTRODUCTION 126
7.2 PHASE III 126
7.2.1 DEVELOPMENT OF BIOLOGICS AND ADVANCED THERAPIES TO SUPPORT MARKET GROWTH 126
7.3 PHASE II 130
7.3.1 NEED FOR GREATER EFFICIENCY AND COMPLIANCE IN TRIAL LOGISTICS TO SUPPORT MARKET GROWTH 130
7.4 PHASE I 133
7.4.1 RISING COMPLEXITY OF INVESTIGATIONAL DRUGS TO DRIVE MARKET GROWTH 133
7.5 PHASE IV 137
7.5.1 INCREASING FOCUS ON PATIENT-CENTRIC APPROACHES TO DRIVE MARKET GROWTH 137
7.6 PHASE BA/BE 140
7.6.1 ACCELERATING GENERIC DRUG APPROVALS THROUGH OPTIMIZED BA/BE STUDIES TO SUPPORT MARKET GROWTH 140
8 CLINICAL TRIAL SUPPLIES MARKET, BY TYPE 144
8.1 INTRODUCTION 145
8.2 SMALL MOLECULES 145
8.2.1 HIGH VOLUME OF SMALL-MOLECULE CLINICAL TRIALS 145
8.3 BIOLOGICS 149
8.3.1 MONOCLONAL ANTIBODIES 153
8.3.1.1 Rising demand for monoclonal antibodies to drive growth 153
8.3.2 VACCINES 156
8.3.2.1 Increased focus on development of novel vaccines to drive growth 156
8.3.3 OTHER BIOLOGICS 160
8.4 MEDICAL DEVICES 163
8.4.1 RISING DEMAND FOR SPECIALIZED LOGISTICS IN MEDICAL DEVICE CLINICAL TRIALS TO DRIVE MARKET GROWTH 163
9 CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA 167
9.1 INTRODUCTION 168
9.2 ONCOLOGY 169
9.2.1 RISING DISEASE BURDEN TO SUPPORT MARKET GROWTH 169
?
9.3 NEUROLOGY 173
9.3.1 INCREASING R&D INVESTMENT TO SUPPORT MARKET GROWTH 173
9.4 RESPIRATORY DISORDERS 177
9.4.1 RISING INCIDENCE OF RESPIRATORY DISORDERS TO SUPPORT MARKET GROWTH 177
9.5 METABOLIC DISORDERS/ENDOCRINOLOGY 180
9.5.1 INCREASING GLOBAL DIABETES POPULATION TO SUPPORT MARKET GROWTH 180
9.6 CARDIOVASCULAR SYSTEM DISORDERS 184
9.6.1 RISING DEMAND IN CLINICAL DIAGNOSTICS TO PROPEL MARKET GROWTH 184
9.7 DERMATOLOGY 187
9.7.1 GROWING FOCUS ON DRUG DEVELOPMENT TO SUPPORT MARKET GROWTH 187
9.8 GASTROINTESTINAL SYSTEM DISORDERS 191
9.8.1 INCREASING INCIDENCE OF LIFESTYLE AND DIETARY RISK FACTORS TO DRIVE DEMAND 191
9.9 IMMUNOLOGICAL DISORDERS 194
9.9.1 GROWING CLINICAL RESEARCH TO SUPPORT MARKET GROWTH 194
9.10 INFECTIOUS DISEASES 198
9.10.1 RISING OUTBREAKS OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH 198
9.11 PSYCHIATRY 202
9.11.1 RISING INCIDENCE OF PSYCHIATRIC DISORDERS TO PROPEL MARKET GROWTH 202
9.12 OPHTHALMOLOGY 205
9.12.1 RISING NUMBER OF OPHTHALMIC PIPELINE DRUGS TO AID MARKET GROWTH 205
9.13 HEMATOLOGY 209
9.13.1 INTEGRATION OF ADVANCED SUPPLY CHAIN TECHNOLOGIES TO FUEL MARKET GROWTH 209
9.14 GENITOURINARY & WOMEN'S HEALTH 212
9.14.1 RISING PREVALENCE OF CHRONIC DISORDERS IN WOMEN TO PROPEL MARKET GROWTH 212
9.15 OTHER THERAPEUTIC AREAS 216
10 CLINICAL TRIAL SUPPLIES MARKET, BY REGION 220
10.1 INTRODUCTION 221
10.2 NORTH AMERICA 221
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 222
10.2.2 US 227
10.2.2.1 Robust hospital infrastructure and drug research & development to stimulate growth 227
10.2.3 CANADA 230
10.2.3.1 Growing preference of pharmaceutical companies to conduct trials to favor growth 230
?
10.3 EUROPE 234
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 234
10.3.2 GERMANY 239
10.3.2.1 Growing focus on reducing approval timelines and high spending by global pharmaceutical players to propel market 239
10.3.3 UK 243
10.3.3.1 Expanding tax credits leading to encourage growth 243
10.3.4 FRANCE 246
10.3.4.1 Evolving regulatory landscape to stimulate growth 246
10.3.5 ITALY 250
10.3.5.1 Increasing number of drug approvals to accelerate growth 250
10.3.6 SPAIN 253
10.3.6.1 Favorable clinical trial network in public health system to sustain growth 253
10.3.7 SWITZERLAND 256
10.3.7.1 Presence of multinational corporations and small and medium-sized pharmaceutical companies to fuel market 256
10.3.8 NETHERLANDS 260
10.3.8.1 Increasing collaborations among pharmaceutical giants to promote growth 260
10.3.9 REST OF EUROPE 263
10.4 ASIA PACIFIC 267
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 267
10.4.2 CHINA 273
10.4.2.1 High proportion of domestic industry-sponsored trials to speed up growth 273
10.4.3 JAPAN 277
10.4.3.1 Increasing focus on lowering regulatory timelines to facilitate growth 277
10.4.4 INDIA 280
10.4.4.1 Rise in early-phase clinical trials to spur growth 280
10.4.5 AUSTRALIA 284
10.4.5.1 Increasing research funding to favor growth 284
10.4.6 SOUTH KOREA 287
10.4.6.1 Growing focus on new drug development research to drive market 287
10.4.7 SINGAPORE 291
10.4.7.1 Advanced research facilities to intensify growth 291
10.4.8 REST OF ASIA PACIFIC 294
10.5 LATIN AMERICA 298
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 298
10.5.2 BRAZIL 302
10.5.2.1 Regulatory improvements to support growth 302
10.5.3 MEXICO 306
10.5.3.1 Expanding landscape of clinical trials to boost market 306
10.5.4 REST OF LATIN AMERICA 309
10.6 MIDDLE EAST 312
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST 312
10.6.2 GCC COUNTRIES 317
10.6.2.1 Saudi Arabia 320
10.6.2.1.1 Booming investments in research infrastructure and life sciences development to aid growth 320
10.6.2.2 UAE 324
10.6.2.2.1 Increasing public-private partnerships and genomic research initiatives to augment growth 324
10.6.2.3 Rest of GCC Countries 327
10.6.3 REST OF MIDDLE EAST 330
10.7 AFRICA 333
10.7.1 GROWING DEMAND FOR OUTSOURCING SERVICES TO DRIVE MARKET GROWTH 333
10.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 334
11 COMPETITIVE LANDSCAPE 338
11.1 INTRODUCTION 338
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 338
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CLINICAL TRIAL SUPPLIES MARKET 338
11.3 REVENUE ANALYSIS, 2020-2024 340
11.4 MARKET SHARE ANALYSIS, 2024 341
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 343
11.5.1 STARS 343
11.5.2 EMERGING LEADERS 343
11.5.3 PERVASIVE PLAYERS 343
11.5.4 PARTICIPANTS 343
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 345
11.5.5.1 Company footprint 345
11.5.5.2 Region footprint 346
11.5.5.3 Service footprint 347
11.5.5.4 Type footprint 348
11.5.5.5 End-user footprint 349
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 349
11.6.1 PROGRESSIVE COMPANIES 349
11.6.2 RESPONSIVE COMPANIES 349
11.6.3 DYNAMIC COMPANIES 350
11.6.4 STARTING BLOCKS 350
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 351
11.6.5.1 Detailed list of key startups/SMEs 351
11.6.5.2 Competitive benchmarking of key startups/SMEs 352
?
11.7 COMPANY VALUATION & FINANCIAL METRICS 353
11.7.1 COMPANY VALUATION 353
11.7.2 FINANCIAL METRICS 353
11.8 BRAND/SERVICE COMPARISON 354
11.9 COMPETITIVE SCENARIO 355
11.9.1 DEALS 355
11.9.2 EXPANSIONS 356
12 COMPANY PROFILES 357
12.1 KEY PLAYERS 357
12.1.1 THERMO FISHER SCIENTIFIC INC. 357
12.1.1.1 Business overview 357
12.1.1.2 Services offered 358
12.1.1.3 Recent developments 359
12.1.1.3.1 Service launches 359
12.1.1.3.2 Deals 359
12.1.1.3.3 Expansions 360
12.1.1.4 MnM view 360
12.1.1.4.1 Right to win 360
12.1.1.4.2 Strategic choices 360
12.1.1.4.3 Weaknesses & competitive threats 360
12.1.2 NOVO HOLDINGS A/S 361
12.1.2.1 Business overview 361
12.1.2.2 Services offered 362
12.1.2.3 Recent developments 363
12.1.2.3.1 Deals 363
12.1.2.3.2 Expansions 364
12.1.2.4 MnM view 364
12.1.2.4.1 Right to win 364
12.1.2.4.2 Strategic choices 364
12.1.2.4.3 Weaknesses & competitive threats 365
12.1.3 UNITED PARCEL SERVICE OF AMERICA, INC. 366
12.1.3.1 Business overview 366
12.1.3.2 Services offered 366
12.1.3.3 MnM view 367
12.1.3.3.1 Right to win 367
12.1.3.3.2 Strategic choices 367
12.1.3.3.3 Weaknesses & competitive threats 368
?
12.1.4 EUROFINS SCIENTIFIC 369
12.1.4.1 Business overview 369
12.1.4.2 Services offered 370
12.1.4.3 MnM view 371
12.1.4.3.1 Right to win 371
12.1.4.3.2 Strategic choices 371
12.1.4.3.3 Weaknesses & competitive threats 371
12.1.5 PIRAMAL PHARMA LIMITED 372
12.1.5.1 Business overview 372
12.1.5.2 Services offered 373
12.1.5.3 MnM view 374
12.1.5.3.1 Right to win 374
12.1.5.3.2 Strategic choices 374
12.1.5.3.3 Weaknesses & competitive threats 374
12.1.6 IQVIA 375
12.1.6.1 Business overview 375
12.1.6.2 Services offered 377
12.1.7 ICON PLC 378
12.1.7.1 Business overview 378
12.1.7.2 Services offered 379
12.1.7.3 Recent developments 380
12.1.7.3.1 Deals 380
12.1.8 LONZA 381
12.1.8.1 Business overview 381
12.1.8.2 Services offered 382
12.1.8.3 Recent developments 382
12.1.8.3.1 Deals 382
12.1.9 UNIPHAR GROUP PLC 383
12.1.9.1 Business overview 383
12.1.9.2 Services offered 384
12.1.10 ALMAC GROUP 385
12.1.10.1 Business overview 385
12.1.10.2 Services offered 385
12.1.10.3 Recent developments 386
12.1.10.3.1 Expansions 386
12.1.11 SHARP SERVICES, LLC 387
12.1.11.1 Business overview 387
12.1.11.2 Services offered 387
12.1.12 PCI PHARMA SERVICES 389
12.1.12.1 Business overview 389
12.1.12.2 Services offered 389
12.1.12.3 Recent developments 390
12.1.12.3.1 Expansions 390
12.1.13 PAREXEL INTERNATIONAL (MA) CORPORATION 391
12.1.13.1 Business overview 391
12.1.13.2 Services offered 391
12.1.13.3 Recent developments 392
12.1.13.3.1 Deals 392
12.1.14 BIOCAIR 393
12.1.14.1 Business overview 393
12.1.14.2 Services offered 393
12.2 OTHER PLAYERS 394
12.2.1 CENCORA, INC. 394
12.2.2 CLINIGEN LIMITED 395
12.2.3 KLIFO 396
12.2.4 IPS PHARMA 397
12.2.5 COREX LOGISTICS LIMITED 398
12.2.6 OCT GROUP LLC 399
12.2.7 MYONEX 400
12.2.8 INCEPTUA GROUP 401
12.2.9 ANCILLARE, LP 402
12.2.10 ADALLEN PHARMA 403
12.2.11 CLINICAL SERVICES INTERNATIONAL (CSI) 404
12.2.12 NUVISAN GMBH 405
12.2.13 AENOVA HOLDING GMBH 406
13 APPENDIX 407
13.1 DISCUSSION GUIDE 407
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 411
13.3 CUSTOMIZATION OPTIONS 413
13.4 RELATED REPORTS 413
13.5 AUTHOR DETAILS 414

TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 51
TABLE 2 CLINICAL TRIAL SUPPLIES MARKET: RISK ASSESSMENT ANALYSIS 54
TABLE 3 CLINICAL TRIAL SUPPLIES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 64
TABLE 4 CLINICAL TRIAL SUPPLIES MARKET: PRODUCT MANUFACTURERS 73
TABLE 5 CLINICAL TRIAL SUPPLIES MARKET: SERVICE PROVIDERS 73
TABLE 6 CLINICAL TRIAL SUPPLIES MARKET: END USERS 74
TABLE 7 CLINICAL TRIAL SUPPLIES MARKET: REGULATORY BODIES 74
TABLE 8 CLINICAL TRIAL SUPPLIES MARKET: KEY CONFERENCES AND EVENTS,
2025-2026 79
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 12 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 13 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 14 CLINICAL TRIAL SUPPLIES MARKET: PORTER'S FIVE FORCES ANALYSIS 85
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 88
TABLE 16 KEY BUYING CRITERIA FOR CLINICAL TRIAL SUPPLIES PRODUCTS, BY END USER 89
TABLE 17 CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2023-2030 (USD MILLION) 94
TABLE 18 CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS & DISTRIBUTION SERVICES,
BY REGION, 2023-2030 (USD MILLION) 95
TABLE 19 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS & DISTRIBUTION SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 95
TABLE 20 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS & DISTRIBUTION SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 96
TABLE 21 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS & DISTRIBUTION SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 96
TABLE 22 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS & DISTRIBUTION SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 97
TABLE 23 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS & DISTRIBUTION SERVICES, BY REGION, 2023-2030 (USD MILLION) 97
TABLE 24 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR LOGISTICS & DISTRIBUTION SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 97
TABLE 25 CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES,
BY REGION, 2023-2030 (USD MILLION) 98
TABLE 26 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 99
TABLE 27 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 99
TABLE 28 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 100
TABLE 29 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 100
TABLE 30 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY REGION, 2023-2030 (USD MILLION) 100
TABLE 31 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR COMPARATOR SOURCING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 101
TABLE 32 CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 102
TABLE 33 CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY REGION, 2023-2030 (USD MILLION) 102
TABLE 34 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 102
TABLE 35 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 103
TABLE 36 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 103
TABLE 37 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 104
TABLE 38 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY REGION, 2023-2030 (USD MILLION) 104
TABLE 39 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 104
TABLE 40 PRIMARY PACKAGING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION) 105
TABLE 41 NORTH AMERICA: PRIMARY PACKAGING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 105
TABLE 42 EUROPE: PRIMARY PACKAGING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 106
TABLE 43 ASIA PACIFIC: PRIMARY PACKAGING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 106
TABLE 44 LATIN AMERICA: PRIMARY PACKAGING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 107
TABLE 45 MIDDLE EAST: PRIMARY PACKAGING SERVICES MARKET, BY REGION,
2023-2030 (USD MILLION) 107
TABLE 46 GCC COUNTRIES: PRIMARY PACKAGING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 107
TABLE 47 SECONDARY PACKAGING SERVICES MARKET, BY REGION,
2023-2030 (USD MILLION) 108
TABLE 48 NORTH AMERICA: SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 108
TABLE 49 EUROPE: SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 109
TABLE 50 ASIA PACIFIC: SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 109
TABLE 51 LATIN AMERICA: SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 110
TABLE 52 MIDDLE EAST: SECONDARY PACKAGING SERVICES MARKET, BY REGION,
2023-2030 (USD MILLION) 110
TABLE 53 GCC COUNTRIES: SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 110
TABLE 54 LABELING & BLINDING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION) 111
TABLE 55 NORTH AMERICA: LABELING & BLINDING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 111
TABLE 56 EUROPE: LABELING & BLINDING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 112
TABLE 57 ASIA PACIFIC: LABELING & BLINDING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 112
TABLE 58 LATIN AMERICA: LABELING & BLINDING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 113
TABLE 59 MIDDLE EAST: LABELING & BLINDING SERVICES MARKET, BY REGION,
2023-2030 (USD MILLION) 113
TABLE 60 GCC COUNTRIES: LABELING & BLINDING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 113
TABLE 61 CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES, BY REGION, 2023-2030 (USD MILLION) 114
TABLE 62 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 115
TABLE 63 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES,
BY COUNTRY, 2023-2030 (USD MILLION) 115
TABLE 64 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 116
TABLE 65 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 116
TABLE 66 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES, BY REGION, 2023-2030 (USD MILLION) 116
TABLE 67 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR MANUFACTURING SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 117
TABLE 68 CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE & RETENTION SERVICES,
BY REGION, 2023-2030 (USD MILLION) 118
TABLE 69 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE & RETENTION SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 118
TABLE 70 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE & RETENTION SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 119
TABLE 71 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE & RETENTION SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 119
TABLE 72 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE & RETENTION SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 120
TABLE 73 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE & RETENTION SERVICES, BY REGION, 2023-2030 (USD MILLION) 120
TABLE 74 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR STORAGE & RETENTION SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 120
TABLE 75 CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES, BY REGION,
2023-2030 (USD MILLION) 121
TABLE 76 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES,
BY COUNTRY, 2023-2030 (USD MILLION) 122
TABLE 77 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 122
TABLE 78 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES,
BY COUNTRY, 2023-2030 (USD MILLION) 123
TABLE 79 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES,
BY COUNTRY, 2023-2030 (USD MILLION) 123
TABLE 80 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES,
BY REGION, 2023-2030 (USD MILLION) 123
TABLE 81 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER SERVICES, BY COUNTRY, 2023-2030 (USD MILLION) 124
TABLE 82 CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2023-2030 (USD MILLION) 126
TABLE 83 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III TRIALS, BY REGION,
2023-2030 (USD MILLION) 127
TABLE 84 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 127
TABLE 85 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III TRIALS, BY COUNTRY, 2023-2030 (USD MILLION) 128
TABLE 86 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 128
TABLE 87 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 129
TABLE 88 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III TRIALS,
BY REGION, 2023-2030 (USD MILLION) 129
TABLE 89 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE III TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 129
TABLE 90 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II TRIALS, BY REGION,
2023-2030 (USD MILLION) 130
TABLE 91 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 131
TABLE 92 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II TRIALS, BY COUNTRY, 2023-2030 (USD MILLION) 131
TABLE 93 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 132
TABLE 94 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 132
TABLE 95 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II TRIALS,
BY REGION, 2023-2030 (USD MILLION) 132
TABLE 96 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE II TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 133
TABLE 97 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I TRIALS, BY REGION,
2023-2030 (USD MILLION) 134
TABLE 98 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 134
TABLE 99 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I TRIALS, BY COUNTRY, 2023-2030 (USD MILLION) 135
TABLE 100 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 135
TABLE 101 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 136
TABLE 102 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I TRIALS,
BY REGION, 2023-2030 (USD MILLION) 136
TABLE 103 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE I TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 136
TABLE 104 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV TRIALS, BY REGION,
2023-2030 (USD MILLION) 137
TABLE 105 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 138
TABLE 106 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV TRIALS, BY COUNTRY, 2023-2030 (USD MILLION) 138
TABLE 107 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 139
TABLE 108 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 139
TABLE 109 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV TRIALS,
BY REGION, 2023-2030 (USD MILLION) 139
TABLE 110 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE IV TRIALS,
BY COUNTRY, 2023-2030 (USD MILLION) 140
TABLE 111 CLINICAL TRIAL SUPPLIES MARKET FOR PHASE BA/BE STUDIES, BY REGION, 2023-2030 (USD MILLION) 141
TABLE 112 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE BA/BE STUDIES, BY COUNTRY, 2023-2030 (USD MILLION) 141
TABLE 113 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE BA/BE STUDIES,
BY COUNTRY, 2023-2030 (USD MILLION) 142
TABLE 114 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE BA/BE STUDIES,
BY COUNTRY, 2023-2030 (USD MILLION) 142
TABLE 115 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE BA/BE STUDIES, BY COUNTRY, 2023-2030 (USD MILLION) 143
TABLE 116 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE BA/BE STUDIES,
BY REGION, 2023-2030 (USD MILLION) 143
TABLE 117 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR PHASE BA/BE STUDIES, BY COUNTRY, 2023-2030 (USD MILLION) 143
TABLE 118 CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 145
TABLE 119 CLINICAL TRIAL SUPPLIES MARKET FOR SMALL MOLECULES, BY REGION,
2023-2030 (USD MILLION) 146
TABLE 120 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR SMALL MOLECULES,
BY COUNTRY, 2023-2030 (USD MILLION) 146
TABLE 121 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR SMALL MOLECULES,
BY COUNTRY, 2023-2030 (USD MILLION) 147
TABLE 122 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR SMALL MOLECULES,
BY COUNTRY, 2023-2030 (USD MILLION) 147
TABLE 123 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR SMALL MOLECULES,
BY COUNTRY, 2023-2030 (USD MILLION) 148
TABLE 124 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR SMALL MOLECULES,
BY REGION, 2023-2030 (USD MILLION) 148
TABLE 125 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR SMALL MOLECULES,
BY COUNTRY, 2023-2030 (USD MILLION) 148
TABLE 126 CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 149
TABLE 127 CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY REGION,
2023-2030 (USD MILLION) 150
TABLE 128 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS,
BY COUNTRY, 2023-2030 (USD MILLION) 150
TABLE 129 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY COUNTRY,
2023-2030 (USD MILLION) 151
TABLE 130 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION) 151
TABLE 131 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION) 152
TABLE 132 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY REGION, 2023-2030 (USD MILLION) 152
TABLE 133 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS,
BY COUNTRY, 2023-2030 (USD MILLION) 152
TABLE 134 CLINICAL TRIAL SUPPLIES MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2023-2030 (USD MILLION) 153
TABLE 135 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023-2030 (USD MILLION) 154
TABLE 136 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR MONOCLONAL ANTIBODIES,
BY COUNTRY, 2023-2030 (USD MILLION) 154
TABLE 137 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023-2030 (USD MILLION) 155
TABLE 138 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023-2030 (USD MILLION) 155
TABLE 139 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2023-2030 (USD MILLION) 155
TABLE 140 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023-2030 (USD MILLION) 156
TABLE 141 CLINICAL TRIAL SUPPLIES MARKET FOR VACCINES, BY REGION,
2023-2030 (USD MILLION) 157
TABLE 142 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR VACCINES,
BY COUNTRY, 2023-2030 (USD MILLION) 157
TABLE 143 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR VACCINES, BY COUNTRY,
2023-2030 (USD MILLION) 158
TABLE 144 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR VACCINES, BY COUNTRY, 2023-2030 (USD MILLION) 158
TABLE 145 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR VACCINES, BY COUNTRY, 2023-2030 (USD MILLION) 159
TABLE 146 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR VACCINES, BY REGION, 2023-2030 (USD MILLION) 159
TABLE 147 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR VACCINES, BY COUNTRY, 2023-2030 (USD MILLION) 159
TABLE 148 CLINICAL TRIAL SUPPLIES MARKET FOR OTHER BIOLOGICS, BY REGION,
2023-2030 (USD MILLION) 160
TABLE 149 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER BIOLOGICS,
BY COUNTRY, 2023-2030 (USD MILLION) 161
TABLE 150 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023-2030 (USD MILLION) 161
TABLE 151 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER BIOLOGICS,
BY COUNTRY, 2023-2030 (USD MILLION) 162
TABLE 152 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER BIOLOGICS,
BY COUNTRY, 2023-2030 (USD MILLION) 162
TABLE 153 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER BIOLOGICS,
BY REGION, 2023-2030 (USD MILLION) 162
TABLE 154 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER BIOLOGICS,
BY COUNTRY, 2023-2030 (USD MILLION) 163
TABLE 155 CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES, BY REGION,
2023-2030 (USD MILLION) 164
TABLE 156 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES,
BY COUNTRY, 2023-2030 (USD MILLION) 164
TABLE 157 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023-2030 (USD MILLION) 165
TABLE 158 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES,
BY COUNTRY, 2023-2030 (USD MILLION) 165
TABLE 159 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES,
BY COUNTRY, 2023-2030 (USD MILLION) 166
TABLE 160 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES,
BY REGION, 2023-2030 (USD MILLION) 166
TABLE 161 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR MEDICAL DEVICES,
BY COUNTRY, 2023-2030 (USD MILLION) 166
TABLE 162 CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 168
TABLE 163 US: NUMBER OF NEW CANCER CASES, BY TYPE, 2022 VS. 2040 169
TABLE 164 CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY REGION,
2023-2030 (USD MILLION) 170
TABLE 165 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 170
TABLE 166 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 171
TABLE 167 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 171
TABLE 168 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 172
TABLE 169 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION) 172
TABLE 170 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR ONCOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 172
TABLE 171 CLINICAL TRIAL SUPPLIES MARKET FOR NEUROLOGY, BY REGION,
2023-2030 (USD MILLION) 174
TABLE 172 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR NEUROLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 174
TABLE 173 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 175
TABLE 174 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 175
TABLE 175 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR NEUROLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 176
TABLE 176 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR NEUROLOGY, BY REGION, 2023-2030 (USD MILLION) 176
TABLE 177 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR NEUROLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 176
TABLE 178 CLINICAL TRIAL SUPPLIES MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2023-2030 (USD MILLION) 177
TABLE 179 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 178
TABLE 180 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR RESPIRATORY DISORDERS,
BY COUNTRY, 2023-2030 (USD MILLION) 178
TABLE 181 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 179
TABLE 182 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 179
TABLE 183 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2023-2030 (USD MILLION) 179
TABLE 184 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 180
TABLE 185 CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2023-2030 (USD MILLION) 181
TABLE 186 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 181
TABLE 187 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 182
TABLE 188 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 182
TABLE 189 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 183
TABLE 190 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2023-2030 (USD MILLION) 183
TABLE 191 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 183
TABLE 192 CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY REGION, 2023-2030 (USD MILLION) 184
TABLE 193 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 185
TABLE 194 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 185
TABLE 195 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 186
TABLE 196 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 186
TABLE 197 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY REGION, 2023-2030 (USD MILLION) 186
TABLE 198 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 187
TABLE 199 CLINICAL TRIAL SUPPLIES MARKET FOR DERMATOLOGY, BY REGION,
2023-2030 (USD MILLION) 188
TABLE 200 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR DERMATOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 188
TABLE 201 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 189
TABLE 202 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR DERMATOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 189
TABLE 203 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR DERMATOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 190
TABLE 204 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR DERMATOLOGY,
BY REGION, 2023-2030 (USD MILLION) 190
TABLE 205 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR DERMATOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 190
TABLE 206 CLINICAL TRIAL SUPPLIES MARKET FOR GASTROINTESTINAL SYSTEM DISORDERS, BY REGION, 2023-2030 (USD MILLION) 191
TABLE 207 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR GASTROINTESTINAL SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 192
TABLE 208 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR GASTROINTESTINAL SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 192
TABLE 209 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR GASTROINTESTINAL SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 193
TABLE 210 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR GASTROINTESTINAL SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 193
TABLE 211 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR GASTROINTESTINAL SYSTEM DISORDERS, BY REGION, 2023-2030 (USD MILLION) 194
TABLE 212 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR GASTROINTESTINAL SYSTEM DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 194
TABLE 213 CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2023-2030 (USD MILLION) 195
TABLE 214 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 195
TABLE 215 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 196
TABLE 216 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 196
TABLE 217 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 197
TABLE 218 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2023-2030 (USD MILLION) 197
TABLE 219 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023-2030 (USD MILLION) 197
TABLE 220 CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023-2030 (USD MILLION) 199
TABLE 221 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION) 199
TABLE 222 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2023-2030 (USD MILLION) 200
TABLE 223 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2023-2030 (USD MILLION) 200
TABLE 224 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION) 201
TABLE 225 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES,
BY REGION, 2023-2030 (USD MILLION) 201
TABLE 226 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION) 201
TABLE 227 CLINICAL TRIAL SUPPLIES MARKET FOR PSYCHIATRY, BY REGION,
2023-2030 (USD MILLION) 202
TABLE 228 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PSYCHIATRY,
BY COUNTRY, 2023-2030 (USD MILLION) 203
TABLE 229 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023-2030 (USD MILLION) 203
TABLE 230 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023-2030 (USD MILLION) 204
TABLE 231 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PSYCHIATRY,
BY COUNTRY, 2023-2030 (USD MILLION) 204
TABLE 232 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR PSYCHIATRY, BY REGION, 2023-2030 (USD MILLION) 204
TABLE 233 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR PSYCHIATRY,
BY COUNTRY, 2023-2030 (USD MILLION) 205
TABLE 234 CLINICAL TRIAL SUPPLIES MARKET FOR OPHTHALMOLOGY, BY REGION,
2023-2030 (USD MILLION) 206
TABLE 235 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR OPHTHALMOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 206

TABLE 236 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 207
TABLE 237 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR OPHTHALMOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 207
TABLE 238 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR OPHTHALMOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 208
TABLE 239 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR OPHTHALMOLOGY,
BY REGION, 2023-2030 (USD MILLION) 208
TABLE 240 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR OPHTHALMOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 208
TABLE 241 CLINICAL TRIAL SUPPLIES MARKET FOR HEMATOLOGY, BY REGION,
2023-2030 (USD MILLION) 209
TABLE 242 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR HEMATOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 210
TABLE 243 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 210
TABLE 244 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 211
TABLE 245 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR HEMATOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 211
TABLE 246 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR HEMATOLOGY, BY REGION, 2023-2030 (USD MILLION) 211
TABLE 247 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR HEMATOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 212
TABLE 248 CLINICAL TRIAL SUPPLIES MARKET FOR GENITOURINARY & WOMEN'S HEALTH,
BY REGION, 2023-2030 (USD MILLION) 213
TABLE 249 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY COUNTRY, 2023-2030 (USD MILLION) 213
TABLE 250 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY COUNTRY, 2023-2030 (USD MILLION) 214
TABLE 251 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY COUNTRY, 2023-2030 (USD MILLION) 214
TABLE 252 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY COUNTRY, 2023-2030 (USD MILLION) 215
TABLE 253 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2023-2030 (USD MILLION) 215
TABLE 254 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR GENITOURINARY & WOMEN'S HEALTH, BY COUNTRY, 2023-2030 (USD MILLION) 215
TABLE 255 CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023-2030 (USD MILLION) 216
TABLE 256 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION) 217
TABLE 257 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION) 217
TABLE 258 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION) 218
TABLE 259 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION) 218
TABLE 260 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023-2030 (USD MILLION) 218
TABLE 261 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023-2030 (USD MILLION) 219
TABLE 262 CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2023-2030 (USD MILLION) 221
TABLE 263 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 222
TABLE 264 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 223
TABLE 265 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 224
TABLE 266 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 224
TABLE 267 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 225
TABLE 268 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 225
TABLE 269 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION) 225
TABLE 270 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION) 226
TABLE 271 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 226
TABLE 272 US: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2023-2030 (USD MILLION) 227
TABLE 273 US: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 228
TABLE 274 US: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2023-2030 (USD MILLION) 228
TABLE 275 US: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 228
TABLE 276 US: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 229
TABLE 277 US: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 229
TABLE 278 US: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2023-2030 (USD MILLION) 230
TABLE 279 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 231
TABLE 280 CANADA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 231
TABLE 281 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 232
TABLE 282 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 232
TABLE 283 CANADA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 232
TABLE 284 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 233
TABLE 285 CANADA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 233
TABLE 286 EUROPE: KEY MACROECONOMIC INDICATORS 235
TABLE 287 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 235
TABLE 288 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 236
TABLE 289 EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 236
TABLE 290 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 237
TABLE 291 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 237
TABLE 292 EUROPE: CLINICAL TRIAL SUPPLIES MARKE FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 237
TABLE 293 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 238
TABLE 294 EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 238
TABLE 295 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 240
TABLE 296 GERMANY: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 240
TABLE 297 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 241
TABLE 298 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 241
TABLE 299 GERMANY: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 241
TABLE 300 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 242
TABLE 301 GERMANY: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 242
TABLE 302 UK: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2023-2030 (USD MILLION) 243
TABLE 303 UK: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 244
TABLE 304 UK: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2023-2030 (USD MILLION) 244
TABLE 305 UK: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 244
TABLE 306 UK: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 245
TABLE 307 UK: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 245
TABLE 308 UK: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2023-2030 (USD MILLION) 246
TABLE 309 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 247
TABLE 310 FRANCE: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 247
TABLE 311 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 248
TABLE 312 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 248
TABLE 313 FRANCE: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 248
TABLE 314 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 249
TABLE 315 FRANCE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 249
TABLE 316 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 250
TABLE 317 ITALY: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 251
TABLE 318 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2023-2030 (USD MILLION) 251
TABLE 319 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 251
TABLE 320 ITALY: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 252
TABLE 321 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 252
TABLE 322 ITALY: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 253
TABLE 323 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 253
TABLE 324 SPAIN: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 254
TABLE 325 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2023-2030 (USD MILLION) 254
TABLE 326 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 254
TABLE 327 SPAIN: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 255
TABLE 328 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 255
TABLE 329 SPAIN: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 256
TABLE 330 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 257
TABLE 331 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 257
TABLE 332 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 258
TABLE 333 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 258
TABLE 334 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION) 258
TABLE 335 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 259
TABLE 336 SWITZERLAND: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 259
TABLE 337 NETHERLANDS: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 260
TABLE 338 NETHERLANDS: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 261
TABLE 339 NETHERLANDS: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 261
TABLE 340 NETHERLANDS: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 261
TABLE 341 NETHERLANDS: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION) 262
TABLE 342 NETHERLANDS: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION) 262
TABLE 343 NETHERLANDS: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 263
TABLE 344 REST OF EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 264
TABLE 345 REST OF EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 264
TABLE 346 REST OF EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 265
TABLE 347 REST OF EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 265
TABLE 348 REST OF EUROPE: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION) 265
TABLE 349 REST OF EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION) 266
TABLE 350 REST OF EUROPE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 266
TABLE 351 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 268
TABLE 352 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 270
TABLE 353 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 270
TABLE 354 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 271
TABLE 355 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 271
TABLE 356 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 271
TABLE 357 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 272
TABLE 358 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 272
TABLE 359 ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 273
TABLE 360 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 274
TABLE 361 CHINA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 274
TABLE 362 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2023-2030 (USD MILLION) 275
TABLE 363 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 275
TABLE 364 CHINA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 275
TABLE 365 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 276
TABLE 366 CHINA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 276
TABLE 367 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 277
TABLE 368 JAPAN: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 278
TABLE 369 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2023-2030 (USD MILLION) 278
TABLE 370 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 278
TABLE 371 JAPAN: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 279
TABLE 372 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 279
TABLE 373 JAPAN: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 280
TABLE 374 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 281
TABLE 375 INDIA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 281
TABLE 376 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2023-2030 (USD MILLION) 282
TABLE 377 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 282
TABLE 378 INDIA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 282
TABLE 379 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 283
TABLE 380 INDIA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 283
TABLE 381 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 284
TABLE 382 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 285
TABLE 383 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 285
TABLE 384 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 285
TABLE 385 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 286
TABLE 386 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 286
TABLE 387 AUSTRALIA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 287
TABLE 388 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 288
TABLE 389 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 288
TABLE 390 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 289
TABLE 391 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 289
TABLE 392 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION) 289
TABLE 393 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 290
TABLE 394 SOUTH KOREA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 290
TABLE 395 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 291
TABLE 396 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 292
TABLE 397 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 292
TABLE 398 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 292
TABLE 399 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 293
TABLE 400 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 293
TABLE 401 SINGAPORE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 294
TABLE 402 REST OF ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 295
TABLE 403 REST OF ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 295
TABLE 404 REST OF ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 296
TABLE 405 REST OF ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 296
TABLE 406 REST OF ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS,
BY TYPE, 2023-2030 (USD MILLION) 296
TABLE 407 REST OF ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION) 297
TABLE 408 REST OF ASIA PACIFIC: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 297
TABLE 409 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 299
TABLE 410 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 299
TABLE 411 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 299
TABLE 412 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 300
TABLE 413 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 300
TABLE 414 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 300
TABLE 415 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION) 301
TABLE 416 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION) 301
TABLE 417 LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 302
TABLE 418 BRAZIL: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 303
TABLE 419 BRAZIL: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 303
TABLE 420 BRAZIL: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 304
TABLE 421 BRAZIL: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 304
TABLE 422 BRAZIL: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 304
TABLE 423 BRAZIL: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 305
TABLE 424 BRAZIL: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 305
TABLE 425 MEXICO: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 306
TABLE 426 MEXICO: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 307
TABLE 427 MEXICO: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 307
TABLE 428 MEXICO: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 307
TABLE 429 MEXICO: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 308
TABLE 430 MEXICO: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 308
TABLE 431 MEXICO: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 309
TABLE 432 REST OF LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 309
TABLE 433 REST OF LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 310
TABLE 434 REST OF LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 310
TABLE 435 REST OF LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 310
TABLE 436 REST OF LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS,
BY TYPE, 2023-2030 (USD MILLION) 311
TABLE 437 REST OF LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION) 311
TABLE 438 REST OF LATIN AMERICA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2023-2030 (USD MILLION) 312
TABLE 439 MIDDLE EAST: KEY MACROECONOMIC INDICATORS 313
TABLE 440 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET, BY REGION,
2023-2030 (USD MILLION) 313
TABLE 441 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 314
TABLE 442 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 314
TABLE 443 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 315
TABLE 444 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 315
TABLE 445 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION) 315
TABLE 446 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 316
TABLE 447 MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 316
TABLE 448 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 317
TABLE 449 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 317
TABLE 450 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 318
TABLE 451 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 318
TABLE 452 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 318
TABLE 453 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION) 319
TABLE 454 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION) 319
TABLE 455 GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 320
TABLE 456 SAUDI ARABIA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 321
TABLE 457 SAUDI ARABIA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 321
TABLE 458 SAUDI ARABIA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 322
TABLE 459 SAUDI ARABIA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 322
TABLE 460 SAUDI ARABIA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE, 2023-2030 (USD MILLION) 322
TABLE 461 SAUDI ARABIA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 323
TABLE 462 SAUDI ARABIA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 323
TABLE 463 UAE: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE, 2023-2030 (USD MILLION) 324
TABLE 464 UAE: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 325
TABLE 465 UAE: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE, 2023-2030 (USD MILLION) 325
TABLE 466 UAE: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 325
TABLE 467 UAE: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 326
TABLE 468 UAE: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 326
TABLE 469 UAE: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 327
TABLE 470 REST OF GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 327
TABLE 471 REST OF GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 328
TABLE 472 REST OF GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 328
TABLE 473 REST OF GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 328
TABLE 474 REST OF GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS,
BY TYPE, 2023-2030 (USD MILLION) 329
TABLE 475 REST OF GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION) 329
TABLE 476 REST OF GCC COUNTRIES: CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2023-2030 (USD MILLION) 330
TABLE 477 REST OF MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 330
TABLE 478 REST OF MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 331
TABLE 479 REST OF MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 331
TABLE 480 REST OF MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE,
2023-2030 (USD MILLION) 331
TABLE 481 REST OF MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS,
BY TYPE, 2023-2030 (USD MILLION) 332
TABLE 482 REST OF MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION) 332
TABLE 483 REST OF MIDDLE EAST: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 333
TABLE 484 AFRICA: KEY MACROECONOMIC INDICATORS 334
TABLE 485 AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY SERVICE,
2023-2030 (USD MILLION) 334
TABLE 486 AFRICA: CLINICAL TRIAL SUPPLIES MARKET FOR PACKAGING, LABELING, AND BLINDING SERVICES, BY TYPE, 2023-2030 (USD MILLION) 335
TABLE 487 AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE,
2023-2030 (USD MILLION) 335
TABLE 488 AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY TYPE, 2023-2030 (USD MILLION) 335
TABLE 489 AFRICA: CLINICAL TRIAL SUPPLIES MARKET FOR BIOLOGICS, BY TYPE,
2023-2030 (USD MILLION) 336
TABLE 490 AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA,
2023-2030 (USD MILLION) 336
TABLE 491 AFRICA: CLINICAL TRIAL SUPPLIES MARKET, BY END USER,
2023-2030 (USD MILLION) 337
TABLE 492 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CLINICAL TRIAL SUPPLIES MARKET 338
TABLE 493 CLINICAL TRIAL SUPPLIES MARKET: DEGREE OF COMPETITION 342
TABLE 494 CLINICAL TRIALS SUPPLIES MARKET: REGION FOOTPRINT 346
TABLE 495 CLINICAL TRIAL SUPPLIES MARKET: SERVICE FOOTPRINT 347
TABLE 496 CLINICAL TRIAL SUPPLIES MARKET: TYPE FOOTPRINT 348
TABLE 497 CLINICAL TRIAL SUPPLIES MARKET: END-USER FOOTPRINT 349
TABLE 498 CLINICAL TRIAL SUPPLIES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 351
TABLE 499 CLINICAL TRIAL SUPPLIES MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES 352
TABLE 500 CLINICAL TRIAL SUPPLIES MARKET: DEALS, JANUARY 2021-MARCH 2025 355
TABLE 501 CLINICAL TRIAL SUPPLIES MARKET: EXPANSIONS, JANUARY 2021-MARCH 2025 356
TABLE 502 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 357
TABLE 503 THERMO FISHER SCIENTIFIC INC.: SERVICES OFFERED 358
TABLE 504 THERMO FISHER SCIENTIFIC INC.: SERVICE LAUNCHES,
JANUARY 2021-MARCH 2025 359
TABLE 505 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-MARCH 2025 359
TABLE 506 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-MARCH 2025 360
TABLE 507 NOVO HOLDINGS A/S: COMPANY OVERVIEW 361
TABLE 508 NOVO HOLDINGS A/S: SERVICES OFFERED 362
TABLE 509 NOVO HOLDINGS A/S: DEALS, JANUARY 2021-MARCH 2025 363
TABLE 510 NOVO HOLDINGS A/S: EXPANSIONS, JANUARY 2021-MARCH 2025 364
TABLE 511 UNITED PARCEL SERVICE OF AMERICA, INC.: COMPANY OVERVIEW 366
TABLE 512 UNITED PARCEL SERVICE OF AMERICA, INC.: SERVICES OFFERED 366
TABLE 513 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 369
TABLE 514 EUROFINS SCIENTIFIC: SERVICES OFFERED 370
TABLE 515 PIRAMAL PHARMA LIMITED: COMPANY OVERVIEW 372
TABLE 516 PIRAMAL PHARMA LIMITED: SERVICES OFFERED 373
TABLE 517 IQVIA: COMPANY OVERVIEW 375
TABLE 518 IQVIA: SERVICES OFFERED 377
TABLE 519 ICON PLC: COMPANY OVERVIEW 378
TABLE 520 ICON PLC: SERVICES OFFERED 379
TABLE 521 ICON PLC: DEALS, JANUARY 2021-MARCH 2025 380
TABLE 522 LONZA: COMPANY OVERVIEW 381
TABLE 523 LONZA: SERVICES OFFERED 382
TABLE 524 LONZA: DEALS, JANUARY 2021-MARCH 2025 382
TABLE 525 UNIPHAR GROUP PLC: COMPANY OVERVIEW 383
TABLE 526 UNIPHAR GROUP PLC: SERVICES OFFERED 384
TABLE 527 ALMAC GROUP: COMPANY OVERVIEW 385
TABLE 528 ALMAC GROUP: SERVICES OFFERED 385
TABLE 529 ALMAC GROUP: EXPANSIONS, JANUARY 2021-MARCH 2025 386
TABLE 530 SHARP SERVICES, LLC: COMPANY OVERVIEW 387
TABLE 531 SHARP SERVICES, LLC: SERVICES OFFERED 387
TABLE 532 PCI PHARMA SERVICES: COMPANY OVERVIEW 389
TABLE 533 PCI PHARMA SERVICES: SERVICES OFFERED 389
TABLE 534 PCI PHARMA SERVICES: EXPANSIONS, JANUARY 2021-MARCH 2025 390
TABLE 535 PAREXEL INTERNATIONAL (MA) CORPORATION: COMPANY OVERVIEW 391
TABLE 536 PAREXEL INTERNATIONAL (MA) CORPORATION.: SERVICES OFFERED 391
TABLE 537 PAREXEL INTERNATIONAL (MA) CORPORATION: DEALS,
JANUARY 2021-MARCH 2025 392
TABLE 538 BIOCAIR: COMPANY OVERVIEW 393
TABLE 539 BIOCAIR: SERVICES OFFERED 393
TABLE 540 CENCORA, INC.: COMPANY OVERVIEW 394
TABLE 541 CLINIGEN LIMITED: COMPANY OVERVIEW 395
TABLE 542 KLIFO: COMPANY OVERVIEW 396
TABLE 543 IPS PHARMA: COMPANY OVERVIEW 397
TABLE 544 COREX LOGISTICS LIMITED: COMPANY OVERVIEW 398
TABLE 545 OCT GROUP LLC: COMPANY OVERVIEW 399
TABLE 546 MYONEX: COMPANY OVERVIEW 400
TABLE 547 INCEPTUA GROUP: COMPANY OVERVIEW 401
TABLE 548 ANCILLARE, LP: COMPANY OVERVIEW 402
TABLE 549 ADALLEN PHARMA: COMPANY OVERVIEW 403
TABLE 550 CLINICAL SERVICES INTERNATIONAL (CSI): COMPANY OVERVIEW 404
TABLE 551 NUVISAN GMBH: COMPANY OVERVIEW 405
TABLE 552 AENOVA HOLDING GMBH: COMPANY OVERVIEW 406